Global Custom Market Research Reports Provider Company

phone

Advanced Cell Diagnostics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 17
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Advanced Cell Diagnostics Inc (ACD), a subsidiary of Bio Techne Corp is a developer of cell and tissue-based diagnostic tests for personalized medicine. The companys products include probes, reagent kits, pretreatment kits, software for quantification, and instruments and accessories, among others. It offers services such as start-up assay development service, biomarker validation, custom assay development and validation, and quantitative analysis, among others. ACD products are used in various therapeutic areas including cancer, neuroscience, infectious disease, inflammation, stem cell research and immunotherapy, among others. The company markets its products through a network of distributors across Belgium, Brazil, China, Finland, India, Greece, Italy, Japan, New Zealand and others. ACD is headquartered in Newark, California, the US.

Advanced Cell Diagnostics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced Cell Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 10
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 11
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 12
Advanced Cell Diagnostics Inc - Key Competitors 13
Advanced Cell Diagnostics Inc - Key Employees 14
Advanced Cell Diagnostics Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Apr 19, 2017: RNAscope Technology Reveals Replication of Zika Virus in Brains of Infants with Microcephaly and Placentas of Women with Pregnancy Losses 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables

List of Tables
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced Cell Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 8
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 10
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 11
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 12
Advanced Cell Diagnostics Inc, Key Competitors 13
Advanced Cell Diagnostics Inc, Key Employees 14
Advanced Cell Diagnostics Inc, Subsidiaries 15

List Of Figures

List of Figures
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advanced Cell Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced Cell Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 8

The global market for advanced oil and gas exploration and downhole technology will increase at a compound annual growth rate (CAGR) of 5.8% to reach $233.4 billion in 2021. Using

View Report

Scope of Report: The report covers the worldwide market for these electronic, electro-optical and other modern technologies used in airports: - Air/ground traffic management and control systems. - Landing aids, guidance and

View Report

Report The Global Advanced Driver Assistance System (ADAS) market was valued at $23.8 billion in 2016 and is expected to reach a value of nearly $59.1 billion by 2021, growing

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports